Status:
ACTIVE_NOT_RECRUITING
TRE in Type 2 Diabetes (See Food Study 3)
Lead Sponsor:
University of Minnesota
Conditions:
Type2Diabetes
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, includ...
Eligibility Criteria
Inclusion
- Overweight/obese adults with metformin-only treated type 2 diabetes
- 18-65 years old
- BMI:25-45 kg/m2
- HbA1c: 6.5-8.5%
- Self-reported weight must be stable \[±5 pounds\] for at least 3 months prior to the study
- Owns a smartphone.
Exclusion
- Active or anticipated pregnancy during the study
- type 2 diabetes treated with medications other than metformin
- presence of eating disorders as noted by screening survey.
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2026
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT05290246
Start Date
May 27 2022
End Date
March 31 2026
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455